| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.706 | 0.004 | 0.706 | Non-steroidal antiinflammatory agent | 0.641 0.004 DBMET01576 0.703 0.004 DBMET01577 0.622 0.004 DBMET01501 | ||
| 0.692 | 0.002 | 0.725 | Cyclooxygenase 3 inhibitor | 0.667 0.002 DBMET01576 0.725 0.001 DBMET01577 0.585 0.002 DBMET01501 | DBMET01577 | |
| 0.705 | 0.03 | 0.717 | Antiinflammatory | 0.699 0.031 DBMET01576 0.698 0.031 DBMET01577 0.717 0.028 DBMET01501 | DBMET01501 | |
| 0.467 | 0.005 | 0.566 | Cyclooxygenase 1 inhibitor | 0.448 0.005 DBMET01576 0.451 0.005 DBMET01577 0.566 0.004 DBMET01501 | DBMET01501 | |
| 0.46 | 0.003 | 0.719 | Interleukin 8 antagonist | 0.398 0.004 DBMET01576 0.489 0.003 DBMET01577 0.719 0.002 DBMET01501 | DBMET01501 | |
| 0.48 | 0.056 | 0.48 | Cyclophilin D inhibitor | 0.471 0.059 DBMET01576 0.467 0.061 DBMET01577 0.428 0.076 DBMET01501 | ||
| 0.419 | 0.004 | 0.419 | Succinate dehydrogenase inhibitor | 0.363 0.005 DBMET01576 0.406 0.004 DBMET01577 0.366 0.005 DBMET01501 | ||
| 0.425 | 0.014 | 0.454 | Anesthetic general | 0.389 0.018 DBMET01576 0.424 0.014 DBMET01577 0.454 0.011 DBMET01501 | DBMET01501 | |
| 0.439 | 0.028 | 0.579 | Lipoxygenase inhibitor | 0.507 0.018 DBMET01576 0.579 0.011 DBMET01577 0.371 0.045 DBMET01501 | DBMET01577 | |
| 0.417 | 0.017 | 0.417 | Platelet aggregation inhibitor | 0.362 0.024 DBMET01576 0.339 0.028 DBMET01577 0.231 0.061 DBMET01501 | ||
| 0.451 | 0.051 | 0.481 | 5 Hydroxytryptamine release inhibitor | 0.419 0.067 DBMET01576 0.444 0.054 DBMET01577 0.481 0.039 DBMET01501 | DBMET01501 | |
| 0.425 | 0.043 | 0.599 | Aldehyde oxidase inhibitor | 0.488 0.034 DBMET01576 0.599 0.019 DBMET01577 0.511 0.031 DBMET01501 | DBMET01577 | |
| 0.406 | 0.03 | 0.513 | Interleukin antagonist | 0.409 0.029 DBMET01576 0.422 0.028 DBMET01577 0.513 0.019 DBMET01501 | DBMET01501 | |
| 0.384 | 0.008 | 0.433 | Cyclooxygenase inhibitor | 0.362 0.01 DBMET01576 0.364 0.01 DBMET01577 0.433 0.006 DBMET01501 | DBMET01501 | |
| 0.394 | 0.028 | 0.394 | Platelet antagonist | 0.346 0.039 DBMET01576 0.345 0.039 DBMET01577 0.17 0.126 DBMET01501 | ||
| 0.402 | 0.049 | 0.402 | Antithrombotic | 0.388 0.052 DBMET01576 0.401 0.049 DBMET01577 0.294 0.092 DBMET01501 | ||
| 0.395 | 0.05 | 0.448 | Cholesterol antagonist | 0.363 0.059 DBMET01576 0.448 0.041 DBMET01577 0.345 0.066 DBMET01501 | DBMET01577 | |
| 0.386 | 0.066 | 0.402 | Toll-Like receptor 7 agonist | 0.334 0.091 DBMET01576 0.347 0.083 DBMET01577 0.402 0.059 DBMET01501 | DBMET01501 | |
| 0.386 | 0.066 | 0.397 | Toll-Like receptor agonist | 0.332 0.092 DBMET01576 0.344 0.085 DBMET01577 0.397 0.061 DBMET01501 | DBMET01501 | |
| 0.316 | 0.005 | 0.437 | Prostaglandin antagonist | 0.216 0.006 DBMET01576 0.219 0.006 DBMET01577 0.437 0.004 DBMET01501 | DBMET01501 | |
| 0.32 | 0.011 | 0.335 | Phospholipase A2 inhibitor | 0.32 0.011 DBMET01576 0.335 0.009 DBMET01577 0.255 0.022 DBMET01501 | DBMET01577 | |
| 0.288 | 0.002 | 0.289 | Arachidonic acid antagonist | 0.281 0.003 DBMET01576 0.289 0.002 DBMET01577 0.269 0.003 DBMET01501 | DBMET01577 | |
| 0.295 | 0.014 | 0.32 | Cyclooxygenase 2 inhibitor | 0.275 0.016 DBMET01576 0.277 0.016 DBMET01577 0.32 0.011 DBMET01501 | DBMET01501 | |
| 0.279 | 0.008 | 0.344 | ATPase inhibitor | 0.286 0.007 DBMET01576 0.289 0.007 DBMET01577 0.344 0.004 DBMET01501 | DBMET01501 | |
| 0.312 | 0.075 | 0.342 | Immunostimulant | 0.342 0.067 DBMET01576 0.339 0.068 DBMET01577 0.27 0.089 DBMET01501 | DBMET01576 | |
| 0.342 | 0.113 | 0.416 | Analgesic | 0.349 0.109 DBMET01576 0.329 0.121 DBMET01577 0.416 0.077 DBMET01501 | DBMET01501 | |
| 0.303 | 0.092 | 0.426 | Transcription factor NF kappa B inhibitor | 0.366 0.072 DBMET01576 0.426 0.058 DBMET01577 0.282 0.105 DBMET01501 | DBMET01577 | |
| 0.232 | 0.023 | 0.24 | Insulin secretagoues | 0.212 0.03 DBMET01576 0.227 0.025 DBMET01577 0.24 0.021 DBMET01501 | DBMET01501 | |
| 0.26 | 0.059 | 0.319 | Tyrosine 3 hydroxylase inhibitor | 0.301 0.032 DBMET01576 0.319 0.025 DBMET01577 0.293 0.037 DBMET01501 | DBMET01577 | |
| 0.264 | 0.064 | 0.339 | Gastrin inhibitor | 0.199 0.15 DBMET01576 0.203 0.144 DBMET01577 0.339 0.013 DBMET01501 | DBMET01501 | |
| 0.315 | 0.116 | 0.42 | Histamine release inhibitor | 0.31 0.118 DBMET01576 0.355 0.098 DBMET01577 0.42 0.065 DBMET01501 | DBMET01501 | |
| 0.283 | 0.087 | 0.375 | Interleukin 2 agonist | 0.287 0.083 DBMET01576 0.296 0.076 DBMET01577 0.375 0.035 DBMET01501 | DBMET01501 | |
| 0.286 | 0.095 | 0.316 | Apoptosis antagonist | 0.288 0.094 DBMET01576 0.316 0.075 DBMET01577 | DBMET01577 | |
| 0.22 | 0.037 | 0.22 | Diuretic | 0.193 0.047 DBMET01576 0.176 0.056 DBMET01577 0.189 0.048 DBMET01501 | ||
| 0.196 | 0.013 | 0.196 | Gastric antisecretory | 0.157 0.024 DBMET01576 0.183 0.015 DBMET01577 0.115 0.048 DBMET01501 | ||
| 0.187 | 0.01 | 0.236 | Electrolyte absorption antagonist | 0.153 0.018 DBMET01576 0.125 0.033 DBMET01577 0.236 0.005 DBMET01501 | DBMET01501 | |
| 0.238 | 0.07 | 0.357 | Cyclic AMP phosphodiesterase inhibitor | 0.205 0.09 DBMET01576 0.252 0.062 DBMET01577 0.357 0.024 DBMET01501 | DBMET01501 | |
| 0.191 | 0.027 | 0.191 | Cell adhesion inhibitor | 0.153 0.045 DBMET01576 0.161 0.04 DBMET01577 0.176 0.033 DBMET01501 | ||
| 0.204 | 0.045 | 0.224 | Protein-tyrosine phosphatase inhibitor | 0.217 0.041 DBMET01576 0.224 0.038 DBMET01577 0.118 0.117 DBMET01501 | DBMET01577 | |
| 0.16 | 0.004 | 0.253 | Prostaglandin D2 antagonist | 0.092 0.005 DBMET01576 0.09 0.005 DBMET01577 0.253 0.004 DBMET01501 | DBMET01501 | |
| 0.227 | 0.078 | 0.227 | Hypolipemic | 0.219 0.083 DBMET01576 0.218 0.083 DBMET01577 0.173 0.115 DBMET01501 | ||
| 0.198 | 0.055 | 0.281 | Src kinase inhibitor | 0.18 0.065 DBMET01576 0.186 0.062 DBMET01577 0.281 0.029 DBMET01501 | DBMET01501 | |
| 0.185 | 0.047 | 0.271 | Lck kinase inhibitor | 0.158 0.061 DBMET01576 0.164 0.057 DBMET01577 0.271 0.02 DBMET01501 | DBMET01501 | |
| 0.144 | 0.007 | 0.148 | Elastase 1 inhibitor | 0.132 0.009 DBMET01576 0.132 0.009 DBMET01577 0.148 0.007 DBMET01501 | DBMET01501 | |
| 0.175 | 0.044 | 0.227 | Interleukin 1 antagonist | 0.139 0.066 DBMET01576 0.165 0.049 DBMET01577 0.227 0.024 DBMET01501 | DBMET01501 | |
| 0.174 | 0.043 | 0.246 | Alpha-N-acetylglucosaminidase inhibitor | 0.126 0.072 DBMET01576 0.246 0.024 DBMET01501 | DBMET01501 | |
| 0.139 | 0.012 | 0.161 | Leukotriene antagonist | 0.131 0.013 DBMET01576 0.161 0.009 DBMET01577 0.103 0.02 DBMET01501 | DBMET01577 | |
| 0.133 | 0.009 | 0.135 | CDC25B inhibitor | 0.13 0.009 DBMET01576 0.135 0.008 DBMET01577 0.081 0.027 DBMET01501 | DBMET01577 | |
| 0.13 | 0.006 | 0.13 | Thromboxane antagonist | 0.1 0.011 DBMET01576 0.107 0.009 DBMET01577 0.102 0.01 DBMET01501 | ||
| 0.163 | 0.04 | 0.204 | Interleukin 4 antagonist | 0.204 0.021 DBMET01576 0.199 0.023 DBMET01577 0.118 0.088 DBMET01501 | DBMET01576 | |
| 0.153 | 0.031 | 0.186 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.079 DBMET01576 0.129 0.057 DBMET01577 0.186 0.012 DBMET01501 | DBMET01501 | |
| 0.146 | 0.027 | 0.228 | HIV-1 integrase (Overall Integration) inhibitor | 0.115 0.043 DBMET01576 0.145 0.027 DBMET01577 0.228 0.007 DBMET01501 | DBMET01501 | |
| 0.196 | 0.077 | 0.206 | Insulin sensitizer | 0.181 0.094 DBMET01576 0.206 0.067 DBMET01577 0.177 0.098 DBMET01501 | DBMET01577 | |
| 0.167 | 0.05 | 0.167 | Cytokine production inhibitor | 0.114 0.095 DBMET01576 0.151 0.062 DBMET01577 | ||
| 0.156 | 0.043 | 0.175 | Protein-tyrosine phosphatase 1B inhibitor | 0.168 0.039 DBMET01576 0.175 0.037 DBMET01577 | DBMET01577 | |
| 0.115 | 0.005 | 0.115 | Thromboxane A2 antagonist | 0.091 0.01 DBMET01576 0.095 0.009 DBMET01577 0.093 0.009 DBMET01501 | ||
| 0.187 | 0.078 | 0.223 | Platelet adhesion inhibitor | 0.223 0.06 DBMET01576 0.208 0.067 DBMET01577 | DBMET01576 | |
| 0.135 | 0.028 | 0.195 | Interleukin 2 antagonist | 0.115 0.053 DBMET01576 0.119 0.046 DBMET01577 0.195 0.008 DBMET01501 | DBMET01501 | |
| 0.121 | 0.016 | 0.177 | Sphingosine 1-phosphate receptor 4 agonist | 0.104 0.023 DBMET01576 0.095 0.027 DBMET01577 0.177 0.005 DBMET01501 | DBMET01501 | |
| 0.115 | 0.014 | 0.203 | NMDA receptor agonist | 0.08 0.029 DBMET01576 0.076 0.032 DBMET01577 0.203 0.005 DBMET01501 | DBMET01501 | |
| 0.234 | 0.134 | 0.268 | Thyroid hormone antagonist | 0.261 0.116 DBMET01576 0.268 0.112 DBMET01577 0.256 0.12 DBMET01501 | DBMET01577 | |
| 0.163 | 0.064 | 0.172 | Hexokinase inhibitor | 0.153 0.076 DBMET01576 0.172 0.056 DBMET01577 0.171 0.057 DBMET01501 | DBMET01577 | |
| 0.162 | 0.064 | 0.189 | Interferon gamma antagonist | 0.189 0.045 DBMET01576 0.187 0.046 DBMET01577 0.187 0.046 DBMET01501 | DBMET01576 | |
| 0.118 | 0.019 | 0.137 | Vanilloid agonist | 0.129 0.015 DBMET01576 0.137 0.013 DBMET01577 | DBMET01577 | |
| 0.118 | 0.02 | 0.207 | Prostaglandin-E synthase inhibitor | 0.095 0.03 DBMET01576 0.102 0.026 DBMET01577 0.207 0.005 DBMET01501 | DBMET01501 | |
| 0.118 | 0.021 | 0.122 | Peroxisome proliferator-activated receptor gamma agonist | 0.11 0.023 DBMET01576 0.11 0.023 DBMET01577 0.122 0.019 DBMET01501 | DBMET01501 | |
| 0.143 | 0.047 | 0.16 | Vanilloid 1 agonist | 0.149 0.04 DBMET01576 0.16 0.029 DBMET01577 0.114 0.102 DBMET01501 | DBMET01577 | |
| 0.12 | 0.024 | 0.12 | Cell adhesion molecule inhibitor | 0.087 0.045 DBMET01576 0.092 0.04 DBMET01577 0.109 0.029 DBMET01501 | ||
| 0.14 | 0.045 | 0.235 | Cystathionine beta-synthase inhibitor | 0.173 0.032 DBMET01576 0.235 0.017 DBMET01577 0.171 0.032 DBMET01501 | DBMET01577 | |
| 0.119 | 0.026 | 0.165 | Adrenaline agonist | 0.149 0.015 DBMET01576 0.165 0.012 DBMET01577 0.118 0.026 DBMET01501 | DBMET01577 | |
| 0.117 | 0.023 | 0.172 | Bile acid receptor antagonist | 0.127 0.014 DBMET01576 0.128 0.014 DBMET01577 0.172 0.005 DBMET01501 | DBMET01501 | |
| 0.106 | 0.014 | 0.146 | NMDA receptor glycine site agonist | 0.072 0.035 DBMET01576 0.071 0.035 DBMET01577 0.146 0.005 DBMET01501 | DBMET01501 | |
| 0.121 | 0.03 | 0.147 | ABCA1 expression enhancer | 0.114 0.035 DBMET01576 0.115 0.034 DBMET01577 0.147 0.018 DBMET01501 | DBMET01501 | |
| 0.236 | 0.148 | 0.255 | Vasodilator, coronary | 0.209 0.174 DBMET01576 0.255 0.129 DBMET01577 | DBMET01577 | |
| 0.124 | 0.037 | 0.222 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 DBMET01576 0.222 0.013 DBMET01501 | DBMET01501 | |
| 0.132 | 0.044 | 0.142 | Mucolytic | 0.138 0.04 DBMET01576 0.142 0.037 DBMET01577 0.109 0.065 DBMET01501 | DBMET01577 | |
| 0.125 | 0.038 | 0.271 | Potassium channel (Ca-activated) activator | 0.127 0.037 DBMET01576 0.134 0.034 DBMET01577 0.271 0.006 DBMET01501 | DBMET01501 | |
| 0.241 | 0.158 | 0.35 | Calcium channel activator | 0.238 0.162 DBMET01577 0.35 0.05 DBMET01501 | DBMET01501 | |
| 0.117 | 0.034 | 0.124 | Triose-phosphate isomerase inhibitor | 0.094 0.054 DBMET01576 0.085 0.066 DBMET01577 0.124 0.03 DBMET01501 | DBMET01501 | |
| 0.089 | 0.007 | 0.151 | CXC chemokine 1 receptor antagonist | 0.091 0.006 DBMET01576 0.091 0.006 DBMET01577 0.151 0.004 DBMET01501 | DBMET01501 | |
| 0.096 | 0.014 | 0.101 | Phosphorylase inhibitor | 0.07 0.02 DBMET01576 0.091 0.014 DBMET01577 0.101 0.013 DBMET01501 | DBMET01501 | |
| 0.129 | 0.046 | 0.177 | 5-Lipoxygenase inhibitor | 0.157 0.035 DBMET01576 0.177 0.029 DBMET01577 0.119 0.051 DBMET01501 | DBMET01577 | |
| 0.111 | 0.029 | 0.197 | Macrophage migration inhibitory factor inhibitor | 0.171 0.011 DBMET01576 0.197 0.008 DBMET01577 | DBMET01577 | |
| 0.112 | 0.03 | 0.117 | Interleukin 5 antagonist | 0.117 0.026 DBMET01576 0.113 0.029 DBMET01577 | DBMET01576 | |
| 0.085 | 0.003 | 0.085 | Prostacyclin agonist | 0.065 0.004 DBMET01576 0.067 0.004 DBMET01577 | ||
| 0.118 | 0.037 | 0.146 | NMDA receptor antagonist | 0.13 0.031 DBMET01576 0.144 0.026 DBMET01577 0.146 0.026 DBMET01501 | DBMET01501 | |
| 0.092 | 0.013 | 0.092 | Nitric oxide donor | 0.086 0.017 DBMET01576 0.087 0.016 DBMET01577 | ||
| 0.192 | 0.12 | 0.241 | Hypoglycemic | 0.222 0.094 DBMET01576 0.241 0.082 DBMET01577 | DBMET01577 | |
| 0.074 | 0.003 | 0.074 | Elastase 3B inhibitor | 0.065 0.003 DBMET01576 0.064 0.003 DBMET01577 0.07 0.003 DBMET01501 | ||
| 0.074 | 0.003 | 0.074 | Elastase 3A inhibitor | 0.065 0.003 DBMET01576 0.064 0.003 DBMET01577 0.07 0.003 DBMET01501 | ||
| 0.074 | 0.003 | 0.074 | Elastase 2B inhibitor | 0.065 0.003 DBMET01576 0.064 0.003 DBMET01577 0.07 0.003 DBMET01501 | ||
| 0.206 | 0.139 | 0.31 | 5 Hydroxytryptamine uptake stimulant | 0.204 0.144 DBMET01577 0.31 0.04 DBMET01501 | DBMET01501 | |
| 0.12 | 0.053 | 0.29 | Ferrochelatase inhibitor | 0.29 0.008 DBMET01501 | DBMET01501 | |
| 0.073 | 0.006 | 0.073 | Prostacyclin antagonist | 0.062 0.009 DBMET01576 0.065 0.008 DBMET01577 0.032 0.024 DBMET01501 | ||
| 0.211 | 0.145 | 0.24 | Thyroid hormone beta antagonist | 0.234 0.129 DBMET01576 0.24 0.125 DBMET01577 0.234 0.129 DBMET01501 | DBMET01577 | |
| 0.193 | 0.127 | 0.193 | 5 Hydroxytryptamine release stimulant | 0.176 0.146 DBMET01576 0.18 0.141 DBMET01577 0.19 0.13 DBMET01501 | ||
| 0.192 | 0.126 | 0.214 | Spasmolytic | 0.195 0.124 DBMET01576 0.214 0.109 DBMET01577 | DBMET01577 | |
| 0.086 | 0.021 | 0.104 | Aldose reductase inhibitor | 0.104 0.017 DBMET01576 0.104 0.017 DBMET01577 0.1 0.018 DBMET01501 | DBMET01577 | |
| 0.068 | 0.004 | 0.068 | Prostaglandin D2 agonist | 0.063 0.005 DBMET01576 0.062 0.005 DBMET01577 | ||
| 0.088 | 0.024 | 0.088 | Peroxisome proliferator-activated receptor gamma antagonist | 0.082 0.031 DBMET01576 0.084 0.028 DBMET01577 0.088 0.024 DBMET01501 | ||
| 0.123 | 0.06 | 0.167 | Interleukin 1b antagonist | 0.093 0.091 DBMET01576 0.104 0.076 DBMET01577 0.167 0.03 DBMET01501 | DBMET01501 | |
| 0.075 | 0.013 | 0.115 | NMDA receptor subunit 3A antagonist | 0.079 0.012 DBMET01576 0.09 0.01 DBMET01577 0.115 0.007 DBMET01501 | DBMET01501 | |
| 0.156 | 0.095 | 0.176 | Amyloid beta precursor protein antagonist | 0.165 0.086 DBMET01576 0.176 0.075 DBMET01577 | DBMET01577 | |
| 0.184 | 0.125 | 0.185 | RNA-directed DNA polymerase inhibitor | 0.171 0.15 DBMET01576 0.185 0.123 DBMET01577 | DBMET01577 | |
| 0.098 | 0.04 | 0.105 | Glutathione S-transferase inhibitor | 0.105 0.033 DBMET01576 0.098 0.039 DBMET01577 0.082 0.058 DBMET01501 | DBMET01576 | |
| 0.071 | 0.013 | 0.075 | Leukotriene C antagonist | 0.067 0.017 DBMET01576 0.072 0.012 DBMET01577 0.075 0.01 DBMET01501 | DBMET01501 | |
| 0.226 | 0.17 | 0.231 | Immunosuppressant | 0.23 0.166 DBMET01576 0.226 0.17 DBMET01577 0.231 0.165 DBMET01501 | DBMET01501 | |
| 0.092 | 0.035 | 0.214 | Histidine decarboxylase inhibitor | 0.116 0.027 DBMET01576 0.149 0.02 DBMET01577 0.214 0.012 DBMET01501 | DBMET01501 | |
| 0.209 | 0.154 | 0.209 | Immunomodulator | 0.198 0.167 DBMET01576 0.2 0.164 DBMET01501 | ||
| 0.11 | 0.058 | 0.316 | GABA C receptor agonist | 0.087 0.083 DBMET01576 0.316 0.008 DBMET01501 | DBMET01501 | |
| 0.085 | 0.034 | 0.096 | Leukotriene synthesis inhibitor | 0.085 0.034 DBMET01576 0.096 0.028 DBMET01577 | DBMET01577 | |
| 0.07 | 0.019 | 0.099 | Diacylglycerol O-acyltransferase inhibitor | 0.099 0.008 DBMET01501 | DBMET01501 | |
| 0.131 | 0.081 | 0.164 | Farnesoid X receptor antagonist | 0.164 0.039 DBMET01576 0.162 0.04 DBMET01577 0.146 0.057 DBMET01501 | DBMET01576 | |
| 0.102 | 0.053 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | 0.126 0.025 DBMET01501 | DBMET01501 | |
| 0.179 | 0.131 | 0.217 | Nitric-oxide synthase stimulant | 0.182 0.123 DBMET01576 0.191 0.105 DBMET01577 0.217 0.063 DBMET01501 | DBMET01501 | |
| 0.214 | 0.169 | 0.328 | Sodium/bile acid cotransporter inhibitor | 0.273 0.105 DBMET01576 0.294 0.085 DBMET01577 0.328 0.055 DBMET01501 | DBMET01501 | |
| 0.057 | 0.014 | 0.066 | Liver X receptor alpha agonist | 0.054 0.016 DBMET01576 0.066 0.01 DBMET01577 0.065 0.01 DBMET01501 | DBMET01577 | |
| 0.166 | 0.123 | 0.192 | Aryl hydrocarbon receptor agonist | 0.192 0.107 DBMET01577 | DBMET01577 | |
| 0.099 | 0.059 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.096 0.063 DBMET01576 0.09 0.072 DBMET01577 0.088 0.075 DBMET01501 | ||
| 0.18 | 0.14 | 0.291 | Interleukin agonist | 0.172 0.147 DBMET01577 0.291 0.053 DBMET01501 | DBMET01501 | |
| 0.046 | 0.007 | 0.088 | NMDA receptor glycine site antagonist | 0.032 0.012 DBMET01576 0.035 0.01 DBMET01577 0.088 0.004 DBMET01501 | DBMET01501 | |
| 0.147 | 0.109 | 0.163 | Neurotensin receptor agonist | 0.153 0.095 DBMET01576 0.163 0.074 DBMET01577 0.163 0.074 DBMET01501 | DBMET01501 | |
| 0.086 | 0.047 | 0.086 | T cell inhibitor | 0.078 0.074 DBMET01577 0.085 0.048 DBMET01501 | ||
| 0.082 | 0.047 | 0.161 | Catalase inhibitor | 0.063 0.062 DBMET01577 0.161 0.024 DBMET01501 | DBMET01501 | |
| 0.081 | 0.047 | 0.108 | Keratolytic | 0.103 0.028 DBMET01576 0.108 0.026 DBMET01577 0.086 0.042 DBMET01501 | DBMET01577 | |
| 0.117 | 0.083 | 0.2 | Amylase inhibitor | 0.142 0.068 DBMET01576 0.2 0.044 DBMET01577 0.129 0.075 DBMET01501 | DBMET01577 | |
| 0.103 | 0.07 | 0.163 | DOPA decarboxylase inhibitor | 0.12 0.045 DBMET01576 0.137 0.03 DBMET01577 0.163 0.016 DBMET01501 | DBMET01501 | |
| 0.044 | 0.012 | 0.046 | Prostaglandin agonist | 0.046 0.011 DBMET01576 0.041 0.013 DBMET01577 0.032 0.02 DBMET01501 | DBMET01576 | |
| 0.067 | 0.035 | 0.081 | Prostaglandin EP2 antagonist | 0.061 0.041 DBMET01576 0.059 0.042 DBMET01577 0.081 0.026 DBMET01501 | DBMET01501 | |
| 0.054 | 0.022 | 0.134 | NMDA receptor subunit 3B antagonist | 0.058 0.02 DBMET01576 0.067 0.017 DBMET01577 0.134 0.008 DBMET01501 | DBMET01501 | |
| 0.053 | 0.021 | 0.073 | Dihydroorotase inhibitor | 0.073 0.01 DBMET01501 | DBMET01501 | |
| 0.044 | 0.012 | 0.052 | Peroxisome proliferator-activated receptor delta antagonist | 0.044 0.012 DBMET01576 0.04 0.014 DBMET01577 0.052 0.009 DBMET01501 | DBMET01501 | |
| 0.133 | 0.103 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.055 DBMET01501 | DBMET01501 | |
| 0.058 | 0.027 | 0.058 | Peroxisome proliferator-activated receptor alpha agonist | 0.048 0.034 DBMET01576 0.049 0.032 DBMET01577 | ||
| 0.089 | 0.058 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.03 DBMET01501 | DBMET01501 | |
| 0.052 | 0.023 | 0.07 | Fructose-1,6-bisphosphatase inhibitor | 0.042 0.036 DBMET01576 0.044 0.033 DBMET01577 0.07 0.012 DBMET01501 | DBMET01501 | |
| 0.045 | 0.015 | 0.048 | Leukotriene C4 antagonist | 0.041 0.021 DBMET01576 0.045 0.015 DBMET01577 0.048 0.012 DBMET01501 | DBMET01501 | |
| 0.124 | 0.096 | 0.14 | CC chemokine 6 receptor antagonist | 0.123 0.1 DBMET01576 0.123 0.099 DBMET01577 0.14 0.04 DBMET01501 | DBMET01501 | |
| 0.098 | 0.071 | 0.15 | Adenylate kinase inhibitor | 0.15 0.026 DBMET01501 | DBMET01501 | |
| 0.035 | 0.009 | 0.058 | Thyroid hormone agonist | 0.058 0.004 DBMET01576 0.057 0.004 DBMET01577 0.032 0.011 DBMET01501 | DBMET01576 | |
| 0.042 | 0.016 | 0.042 | Peroxisome proliferator-activated receptor delta agonist | 0.033 0.024 DBMET01576 0.034 0.022 DBMET01577 0.03 0.027 DBMET01501 | ||
| 0.144 | 0.119 | 0.169 | Phospholipase C inhibitor | 0.169 0.074 DBMET01576 0.162 0.084 DBMET01577 0.166 0.079 DBMET01501 | DBMET01576 | |
| 0.068 | 0.044 | 0.082 | Glutamate (mGluR6) antagonist | 0.082 0.022 DBMET01501 | DBMET01501 | |
| 0.074 | 0.05 | 0.119 | Glutamate decarboxylase inhibitor | 0.091 0.035 DBMET01576 0.098 0.031 DBMET01577 0.119 0.021 DBMET01501 | DBMET01501 | |
| 0.032 | 0.009 | 0.037 | Complement factor 1r inhibitor | 0.027 0.015 DBMET01576 0.028 0.014 DBMET01577 0.037 0.005 DBMET01501 | DBMET01501 | |
| 0.096 | 0.074 | 0.11 | Expectorant | 0.103 0.065 DBMET01576 0.11 0.059 DBMET01577 | DBMET01577 | |
| 0.054 | 0.032 | 0.069 | Aconitate hydratase inhibitor | 0.069 0.019 DBMET01501 | DBMET01501 | |
| 0.056 | 0.035 | 0.087 | DNA helicase inhibitor | 0.052 0.045 DBMET01576 0.053 0.042 DBMET01577 0.087 0.009 DBMET01501 | DBMET01501 | |
| 0.075 | 0.054 | 0.109 | GABA B receptor agonist | 0.073 0.058 DBMET01576 0.086 0.031 DBMET01577 0.109 0.011 DBMET01501 | DBMET01501 | |
| 0.187 | 0.166 | 0.285 | 12-Lipoxygenase inhibitor | 0.238 0.116 DBMET01576 0.285 0.088 DBMET01577 0.209 0.141 DBMET01501 | DBMET01577 | |
| 0.056 | 0.035 | 0.056 | Thromboxane synthase inhibitor | 0.051 0.044 DBMET01501 | ||
| 0.032 | 0.012 | 0.032 | Prostaglandin EP2 agonist | 0.032 0.011 DBMET01576 0.026 0.014 DBMET01577 0.02 0.017 DBMET01501 | ||
| 0.03 | 0.01 | 0.03 | Prostaglandin E2 agonist | 0.03 0.01 DBMET01576 0.028 0.012 DBMET01577 0.024 0.015 DBMET01501 | ||
| 0.068 | 0.049 | 0.069 | Phosphofructokinase-1 inhibitor | 0.06 0.057 DBMET01576 0.069 0.048 DBMET01501 | DBMET01501 | |
| 0.054 | 0.037 | 0.076 | Sphingosine 1-phosphate receptor 5 agonist | 0.076 0.014 DBMET01501 | DBMET01501 | |
| 0.027 | 0.011 | 0.027 | Elastase 2A inhibitor | 0.027 0.01 DBMET01501 | ||
| 0.027 | 0.011 | 0.027 | Elastase 2 inhibitor | 0.027 0.01 DBMET01501 | ||
| 0.022 | 0.006 | 0.027 | Thyroid hormone alpha agonist | 0.027 0.004 DBMET01576 0.023 0.005 DBMET01577 0.023 0.005 DBMET01501 | DBMET01576 | |
| 0.053 | 0.038 | 0.059 | Leukotriene B4 antagonist | 0.055 0.034 DBMET01576 0.059 0.029 DBMET01577 | DBMET01577 | |
| 0.02 | 0.005 | 0.02 | Thromboxane A2 agonist | 0.015 0.012 DBMET01577 0.02 0.006 DBMET01501 | ||
| 0.081 | 0.066 | 0.11 | D-Ala-D-Ala ligase inhibitor | 0.084 0.057 DBMET01576 0.088 0.049 DBMET01577 0.11 0.019 DBMET01501 | DBMET01501 | |
| 0.047 | 0.034 | 0.089 | Carnitine palmitoyltransferase 1B inhibitor | 0.089 0.005 DBMET01501 | DBMET01501 | |
| 0.034 | 0.021 | 0.043 | Liver X receptor beta agonist | 0.034 0.022 DBMET01576 0.033 0.023 DBMET01577 0.043 0.013 DBMET01501 | DBMET01501 | |
| 0.045 | 0.033 | 0.052 | Beta adrenoreceptor agonist | 0.049 0.019 DBMET01576 0.052 0.014 DBMET01577 0.043 0.04 DBMET01501 | DBMET01577 | |
| 0.135 | 0.123 | 0.166 | DNA methyltransferase I inhibitor | 0.163 0.091 DBMET01576 0.166 0.09 DBMET01577 0.147 0.107 DBMET01501 | DBMET01577 | |
| 0.083 | 0.071 | 0.161 | Potassium channel activator | 0.161 0.017 DBMET01501 | DBMET01501 | |
| 0.1 | 0.089 | 0.101 | Photosensitizer | 0.101 0.087 DBMET01576 0.098 0.093 DBMET01577 | DBMET01576 | |
| 0.086 | 0.076 | 0.122 | Aminopeptidase B inhibitor | 0.122 0.051 DBMET01501 | DBMET01501 | |
| 0.112 | 0.102 | 0.143 | Protein kinase stimulant | 0.121 0.092 DBMET01576 0.143 0.073 DBMET01577 0.113 0.101 DBMET01501 | DBMET01577 | |
| 0.061 | 0.053 | 0.077 | Beta adrenoreceptor antagonist | 0.075 0.031 DBMET01576 0.077 0.029 DBMET01577 | DBMET01577 | |
| 0.016 | 0.01 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 DBMET01576 0.022 0.007 DBMET01577 0.023 0.006 DBMET01501 | DBMET01501 | |
| 0.034 | 0.029 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 DBMET01501 | DBMET01501 | |
| 0.066 | 0.062 | 0.087 | Glutamate dehydrogenase inhibitor | 0.087 0.038 DBMET01501 | DBMET01501 | |
| 0.025 | 0.021 | 0.039 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.039 0.011 DBMET01501 | DBMET01501 | |
| 0.09 | 0.086 | 0.105 | Folate antagonist | 0.097 0.07 DBMET01576 0.105 0.057 DBMET01501 | DBMET01501 | |
| 0.023 | 0.02 | 0.028 | Prostaglandin H2 antagonist | 0.028 0.015 DBMET01501 | DBMET01501 | |
| 0.024 | 0.021 | 0.048 | Kynurenine 3 monooxygenase inhibitor | 0.048 0.007 DBMET01501 | DBMET01501 | |
| 0.064 | 0.061 | 0.089 | MDM2 inhibitor | 0.089 0.012 DBMET01501 | DBMET01501 | |
| 0.066 | 0.064 | 0.092 | CDC25A inhibitor | 0.069 0.059 DBMET01576 0.075 0.05 DBMET01577 0.092 0.032 DBMET01501 | DBMET01501 | |
| 0.058 | 0.057 | 0.067 | Beta 2 adrenoreceptor agonist | 0.065 0.032 DBMET01576 0.067 0.025 DBMET01577 0.06 0.05 DBMET01501 | DBMET01577 | |
| 0.124 | 0.123 | 0.156 | Dual specificity phosphatase 3 inhibitor | 0.156 0.092 DBMET01576 0.154 0.093 DBMET01577 0.128 0.119 DBMET01501 | DBMET01576 | |
| 0.206 | 0.206 | 0.329 | 15-Lipoxygenase inhibitor | 0.266 0.152 DBMET01576 0.329 0.112 DBMET01577 0.212 0.2 DBMET01501 | DBMET01577 | |
| 0.024 | 0.024 | 0.033 | Integrin alpha2beta1 antagonist | 0.033 0.009 DBMET01501 | DBMET01501 | |
| 0.034 | 0.035 | 0.114 | Kainate receptor antagonist | 0.114 0.006 DBMET01501 | DBMET01501 | |
| 0.158 | 0.159 | 0.183 | ErbB-1 antagonist | 0.16 0.154 DBMET01576 0.163 0.147 DBMET01577 0.183 0.111 DBMET01501 | DBMET01501 | |
| 0.043 | 0.044 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 DBMET01501 | DBMET01501 | |
| 0.044 | 0.046 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.035 DBMET01501 | DBMET01501 | |
| 0.068 | 0.071 | 0.107 | Platelet growth factor antagonist | 0.107 0.037 DBMET01501 | DBMET01501 | |
| 0.033 | 0.035 | 0.046 | Integrin alpha2 antagonist | 0.046 0.014 DBMET01501 | DBMET01501 | |
| 0.025 | 0.028 | 0.036 | Liver X receptor alpha antagonist | 0.027 0.025 DBMET01576 0.029 0.02 DBMET01577 0.036 0.011 DBMET01501 | DBMET01501 | |
| 0.051 | 0.054 | 0.071 | Carbamoyl phosphate synthetase inhibitor | 0.071 0.034 DBMET01501 | DBMET01501 | |
| 0.019 | 0.023 | 0.021 | Prostaglandin F2 alpha agonist | 0.021 0.018 DBMET01576 0.021 0.019 DBMET01577 | DBMET01577 | |
| 0.069 | 0.073 | 0.104 | Carbonic anhydrase VI inhibitor | 0.084 0.053 DBMET01576 0.104 0.037 DBMET01577 0.084 0.052 DBMET01501 | DBMET01577 | |
| 0.03 | 0.034 | 0.039 | Glutamate (mGluR4) agonist | 0.039 0.017 DBMET01501 | DBMET01501 | |
| 0.006 | 0.011 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 DBMET01576 0.012 0.004 DBMET01577 | DBMET01576 | |
| 0.033 | 0.038 | 0.048 | Glutamate (mGluR8) agonist | 0.048 0.013 DBMET01501 | DBMET01501 | |
| 0.029 | 0.034 | 0.036 | Purinergic P2Y2 antagonist | 0.036 0.02 DBMET01501 | DBMET01501 | |
| 0.019 | 0.024 | 0.025 | Beta 1 adrenoreceptor agonist | 0.021 0.02 DBMET01576 0.025 0.012 DBMET01577 | DBMET01577 | |
| 0.021 | 0.027 | 0.043 | CXC chemokine 2 receptor antagonist | 0.024 0.022 DBMET01576 0.043 0.007 DBMET01501 | DBMET01501 | |
| 0.029 | 0.035 | 0.036 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.022 DBMET01501 | DBMET01501 | |
| 0.022 | 0.029 | 0.042 | Liver X receptor beta antagonist | 0.026 0.023 DBMET01577 0.042 0.012 DBMET01501 | DBMET01501 | |
| 0.2 | 0.207 | 0.32 | GABA C receptor rho-3 antagonist | 0.24 0.163 DBMET01577 0.32 0.103 DBMET01501 | DBMET01501 | |
| 0.029 | 0.035 | 0.045 | Carnitine palmitoyltransferase 1 inhibitor | 0.045 0.011 DBMET01501 | DBMET01501 | |
| 0.042 | 0.049 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.052 0.033 DBMET01576 0.056 0.028 DBMET01577 | DBMET01577 | |
| 0.036 | 0.043 | 0.038 | VCAM-1 antagonist | 0.038 0.031 DBMET01501 | DBMET01501 | |
| 0.036 | 0.043 | 0.038 | VCAM antagonist | 0.038 0.031 DBMET01501 | DBMET01501 | |
| 0.028 | 0.036 | 0.046 | Carnitine palmitoyltransferase inhibitor | 0.046 0.011 DBMET01501 | DBMET01501 | |
| 0.02 | 0.028 | 0.044 | AMPA 1 receptor antagonist | 0.044 0.013 DBMET01501 | DBMET01501 | |
| 0.019 | 0.028 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.018 DBMET01501 | DBMET01501 | |
| 0.054 | 0.063 | 0.063 | Caspase 9 inhibitor | 0.063 0.042 DBMET01501 | DBMET01501 | |
| 0.039 | 0.048 | 0.086 | NMDA 2A receptor antagonist | 0.047 0.04 DBMET01576 0.046 0.042 DBMET01577 0.086 0.017 DBMET01501 | DBMET01501 | |
| 0.135 | 0.146 | 0.177 | Catenin beta inhibitor | 0.139 0.134 DBMET01576 0.151 0.104 DBMET01577 0.177 0.056 DBMET01501 | DBMET01501 | |
| 0.051 | 0.061 | 0.085 | Purinergic P2X1 antagonist | 0.061 0.042 DBMET01576 0.085 0.022 DBMET01501 | DBMET01501 | |
| 0.106 | 0.117 | 0.246 | Peroxidase inhibitor | 0.18 0.065 DBMET01576 0.246 0.048 DBMET01577 0.229 0.052 DBMET01501 | DBMET01577 | |
| 0.093 | 0.104 | 0.116 | Caspase 3 inhibitor | 0.116 0.065 DBMET01501 | DBMET01501 | |
| 0.032 | 0.044 | 0.055 | Carbonic anhydrase IV inhibitor | 0.055 0.021 DBMET01501 | DBMET01501 | |
| 0.019 | 0.031 | 0.024 | Prostaglandin EP4 antagonist | 0.024 0.021 DBMET01501 | DBMET01501 | |
| 0.078 | 0.09 | 0.123 | Creatine kinase inhibitor | 0.099 0.061 DBMET01576 0.113 0.047 DBMET01577 0.123 0.039 DBMET01501 | DBMET01501 | |
| 0.034 | 0.046 | 0.051 | Glutamate (mGluR group III) agonist | 0.051 0.023 DBMET01501 | DBMET01501 | |
| 0.121 | 0.135 | 0.146 | Dual specificity phosphatase inhibitor | 0.146 0.099 DBMET01576 0.146 0.098 DBMET01577 | DBMET01577 | |
| 0.039 | 0.053 | 0.065 | Dihydroorotate dehydrogenase inhibitor | 0.065 0.024 DBMET01501 | DBMET01501 | |
| 0.081 | 0.096 | 0.103 | Interleukin 12 antagonist | 0.095 0.063 DBMET01576 0.103 0.049 DBMET01577 | DBMET01577 | |
| 0.034 | 0.049 | 0.044 | Liver X receptor agonist | 0.044 0.03 DBMET01501 | DBMET01501 | |
| 0.127 | 0.142 | 0.156 | DNA methylase inhibitor | 0.154 0.114 DBMET01576 0.156 0.112 DBMET01577 0.148 0.119 DBMET01501 | DBMET01577 | |
| 0.045 | 0.061 | 0.081 | Biliverdin reductase inhibitor | 0.081 0.025 DBMET01501 | DBMET01501 | |
| 0.018 | 0.035 | 0.046 | AMPA 3 receptor antagonist | 0.046 0.01 DBMET01501 | DBMET01501 | |
| 0.052 | 0.07 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 DBMET01576 0.078 0.039 DBMET01577 0.089 0.032 DBMET01501 | DBMET01501 | |
| 0.133 | 0.151 | 0.142 | Anticonvulsant | 0.142 0.139 DBMET01501 | DBMET01501 | |
| 0.007 | 0.025 | 0.022 | Integrin alpha4beta1 antagonist | 0.022 0.009 DBMET01501 | DBMET01501 | |
| 0.044 | 0.063 | 0.066 | Heparanase inhibitor | 0.066 0.015 DBMET01501 | DBMET01501 | |
| 0.116 | 0.137 | 0.171 | Sphingosine 1-phosphate receptor 5 antagonist | 0.171 0.033 DBMET01501 | DBMET01501 | |
| 0.122 | 0.143 | 0.152 | Interleukin 6 antagonist | 0.152 0.086 DBMET01501 | DBMET01501 | |
| 0.023 | 0.045 | 0.051 | Integrin antagonist | 0.051 0.027 DBMET01501 | DBMET01501 | |
| 0.029 | 0.051 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET01501 | DBMET01501 | |
| 0.077 | 0.099 | 0.115 | Carbonic anhydrase III inhibitor | 0.092 0.071 DBMET01576 0.115 0.048 DBMET01577 0.096 0.067 DBMET01501 | DBMET01577 | |
| 0.014 | 0.036 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET01501 | DBMET01501 | |
| 0.012 | 0.035 | 0.015 | CC chemokine 10 receptor antagonist | 0.015 0.011 DBMET01501 | DBMET01501 | |
| 0.073 | 0.098 | 0.089 | Hematopoietic | 0.089 0.052 DBMET01501 | DBMET01501 | |
| 0.08 | 0.105 | 0.114 | Carbonic anhydrase XV inhibitor | 0.096 0.074 DBMET01577 0.114 0.052 DBMET01501 | DBMET01501 | |
| 0.035 | 0.059 | 0.046 | Prostaglandin E2 antagonist | 0.046 0.04 DBMET01501 | DBMET01501 | |
| 0.066 | 0.091 | 0.081 | Myeloperoxidase inhibitor | 0.079 0.068 DBMET01576 0.081 0.065 DBMET01577 | DBMET01577 | |
| 0.019 | 0.044 | 0.034 | Liver X receptor antagonist | 0.034 0.018 DBMET01501 | DBMET01501 | |
| 0.075 | 0.1 | 0.094 | UDP-glucose 4-epimerase inhibitor | 0.09 0.073 DBMET01576 0.094 0.067 DBMET01501 | DBMET01501 | |
| 0.076 | 0.102 | 0.091 | Potassium channel (Voltage-sensitive) activator | 0.091 0.066 DBMET01501 | DBMET01501 | |
| 0.015 | 0.042 | 0.073 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.073 0.005 DBMET01501 | DBMET01501 | |
| 0.082 | 0.109 | 0.112 | DNA polymerase I inhibitor | 0.098 0.088 DBMET01576 0.112 0.074 DBMET01577 | DBMET01577 | |
| 0.033 | 0.06 | 0.057 | Kainate receptor agonist | 0.057 0.008 DBMET01501 | DBMET01501 | |
| 0.117 | 0.145 | 0.161 | MAP kinase 3 inhibitor | 0.161 0.052 DBMET01501 | DBMET01501 | |
| 0.054 | 0.082 | 0.082 | Aminopeptidase I inhibitor | 0.082 0.04 DBMET01501 | DBMET01501 | |
| 0.032 | 0.06 | 0.036 | Integrin alpha1beta1 antagonist | 0.036 0.033 DBMET01501 | DBMET01501 | |
| 0.03 | 0.058 | 0.069 | AMPA 4 receptor antagonist | 0.069 0.008 DBMET01501 | DBMET01501 | |
| 0.048 | 0.076 | 0.072 | Prostaglandin F2 alpha antagonist | 0.056 0.053 DBMET01576 0.072 0.03 DBMET01501 | DBMET01501 | |
| 0.075 | 0.103 | 0.107 | MAP kinase kinase 1 inhibitor | 0.107 0.048 DBMET01501 | DBMET01501 | |
| 0.025 | 0.054 | 0.06 | p53 inhibitor | 0.06 0.009 DBMET01501 | DBMET01501 | |
| 0.069 | 0.099 | 0.146 | Monophenol monooxygenase inhibitor | 0.117 0.063 DBMET01576 0.146 0.049 DBMET01577 | DBMET01577 | |
| 0.058 | 0.088 | 0.1 | GABA aminotransferase inhibitor | 0.1 0.027 DBMET01501 | DBMET01501 | |
| 0.032 | 0.063 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 DBMET01501 | DBMET01501 | |
| 0.011 | 0.042 | 0.034 | Integrin alpha4 antagonist | 0.034 0.015 DBMET01501 | DBMET01501 | |
| 0.076 | 0.108 | 0.174 | Protein kinase (CK2) alpha inhibitor | 0.174 0.031 DBMET01501 | DBMET01501 | |
| 0.043 | 0.074 | 0.079 | NMDA 2C receptor antagonist | 0.079 0.026 DBMET01501 | DBMET01501 | |
| 0.051 | 0.083 | 0.077 | Carbonic anhydrase XIII inhibitor | 0.077 0.053 DBMET01577 0.067 0.062 DBMET01501 | DBMET01577 | |
| 0.036 | 0.068 | 0.054 | Maillard reaction inhibitor | 0.048 0.045 DBMET01577 0.054 0.039 DBMET01501 | DBMET01501 | |
| 0.08 | 0.112 | 0.136 | c-Src kinase inhibitor | 0.136 0.064 DBMET01501 | DBMET01501 | |
| 0.051 | 0.085 | 0.074 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 DBMET01501 | DBMET01501 | |
| 0.082 | 0.117 | 0.152 | M18 aspartyl aminopeptidase inhibitor | 0.111 0.079 DBMET01576 0.152 0.051 DBMET01577 | DBMET01577 | |
| 0.036 | 0.072 | 0.061 | Alcohol oxidase inhibitor | 0.061 0.035 DBMET01501 | DBMET01501 | |
| 0.033 | 0.07 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.033 DBMET01501 | DBMET01501 | |
| 0.051 | 0.089 | 0.067 | Cathepsin G inhibitor | 0.067 0.057 DBMET01501 | DBMET01501 | |
| 0.02 | 0.058 | 0.04 | ATP citrate lysase inhibitor | 0.04 0.013 DBMET01501 | DBMET01501 | |
| 0.006 | 0.045 | 0.054 | Kainate receptor 1 antagonist | 0.054 0.005 DBMET01501 | DBMET01501 | |
| 0.08 | 0.119 | 0.132 | Cholesterol synthesis inhibitor | 0.096 0.093 DBMET01577 0.132 0.055 DBMET01501 | DBMET01501 | |
| 0.011 | 0.049 | 0.018 | Complement factor D inhibitor | 0.018 0.012 DBMET01501 | DBMET01501 | |
| 0.063 | 0.102 | 0.077 | Sphingosine 1-phosphate receptor antagonist | 0.077 0.053 DBMET01501 | DBMET01501 | |
| 0.008 | 0.048 | 0.027 | VLA-4 antagonist | 0.027 0.018 DBMET01501 | DBMET01501 | |
| 0.019 | 0.059 | 0.033 | Fumarate hydratase inhibitor | 0.033 0.025 DBMET01501 | DBMET01501 | |
| 0.048 | 0.088 | 0.063 | ZAP-70 protein tyrosine kinase inhibitor | 0.063 0.057 DBMET01501 | DBMET01501 | |
| 0.07 | 0.111 | 0.091 | Estrogen-related receptor beta agonist | 0.091 0.038 DBMET01576 0.085 0.053 DBMET01577 0.079 0.072 DBMET01501 | DBMET01576 | |
| 0.049 | 0.093 | 0.123 | Potassium channel large-conductance Ca-activated activator | 0.123 0.016 DBMET01501 | DBMET01501 | |
| 0.013 | 0.058 | 0.027 | AMPA 2 receptor antagonist | 0.027 0.024 DBMET01501 | DBMET01501 | |
| 0.023 | 0.069 | 0.04 | Glutamate (mGluR3) antagonist | 0.04 0.021 DBMET01501 | DBMET01501 | |
| 0.066 | 0.112 | 0.09 | Mediator release inhibitor | 0.09 0.082 DBMET01577 | DBMET01577 | |
| 0.045 | 0.092 | 0.071 | Carbonic anhydrase VA inhibitor | 0.071 0.045 DBMET01501 | DBMET01501 | |
| 0.149 | 0.198 | 0.168 | Peptidyltransferase inhibitor | 0.168 0.151 DBMET01577 | DBMET01577 | |
| 0.014 | 0.066 | 0.029 | Carnitine palmitoyltransferase 1A inhibitor | 0.029 0.019 DBMET01501 | DBMET01501 | |
| 0.035 | 0.087 | 0.057 | Protein kinase C theta inhibitor | 0.057 0.041 DBMET01501 | DBMET01501 | |
| 0.013 | 0.071 | 0.029 | Sirtuin 2 inhibitor | 0.029 0.027 DBMET01501 | DBMET01501 | |
| 0.026 | 0.083 | 0.043 | Potassium channel Kv1.1 blocker | 0.043 0.019 DBMET01501 | DBMET01501 | |
| 0.039 | 0.098 | 0.061 | Dihydroorotate oxidase inhibitor | 0.061 0.028 DBMET01501 | DBMET01501 | |
| 0.031 | 0.09 | 0.058 | Argininosuccinate synthase inhibitor | 0.058 0.038 DBMET01501 | DBMET01501 | |
| 0.099 | 0.159 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.052 DBMET01501 | DBMET01501 | |
| 0.007 | 0.067 | 0.016 | Alpha 2a adrenoreceptor agonist | 0.016 0.014 DBMET01501 | DBMET01501 | |
| 0.081 | 0.141 | 0.117 | M17 leucyl aminopeptidase inhibitor | 0.117 0.08 DBMET01501 | DBMET01501 | |
| 0.037 | 0.099 | 0.063 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET01501 | DBMET01501 | |
| 0.071 | 0.134 | 0.129 | Protein-tyrosine kinase Lyn inhibitor | 0.129 0.078 DBMET01501 | DBMET01501 | |
| 0.021 | 0.092 | 0.042 | AMPA receptor antagonist | 0.042 0.04 DBMET01501 | DBMET01501 | |
| 0.069 | 0.143 | 0.087 | Glutamate release inhibitor | 0.087 0.068 DBMET01501 | DBMET01501 | |
| 0.118 | 0.194 | 0.167 | Neurotrophic factor enhancer | 0.167 0.115 DBMET01577 0.158 0.127 DBMET01501 | DBMET01577 | |
| 0.015 | 0.092 | 0.031 | Retinoid X alpha receptor agonist | 0.031 0.029 DBMET01501 | DBMET01501 | |
| 0.1 | 0.179 | 0.137 | GABA C receptor rho-2 antagonist | 0.137 0.094 DBMET01501 | DBMET01501 | |
| 0.153 | 0.234 | 0.219 | Angiogenesis inhibitor | 0.219 0.149 DBMET01501 | DBMET01501 | |
| 0.215 | 0.298 | 0.337 | Caspase 9 stimulant | 0.282 0.214 DBMET01577 0.337 0.156 DBMET01501 | DBMET01501 | |
| 0.032 | 0.116 | 0.063 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 DBMET01501 | DBMET01501 | |
| 0.021 | 0.106 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 DBMET01501 | DBMET01501 | |
| 0.063 | 0.15 | 0.126 | GABA C receptor rho-1 antagonist | 0.126 0.035 DBMET01501 | DBMET01501 | |
| 0.036 | 0.124 | 0.095 | Porphobilinogen synthase inhibitor | 0.095 0.038 DBMET01501 | DBMET01501 | |
| 0.066 | 0.154 | 0.136 | GABA C receptor antagonist | 0.136 0.038 DBMET01501 | DBMET01501 | |
| 0.011 | 0.099 | 0.056 | Kainate receptor 2 antagonist | 0.056 0.013 DBMET01501 | DBMET01501 | |
| 0.013 | 0.101 | 0.031 | Free fatty acid receptor 1 antagonist | 0.031 0.027 DBMET01501 | DBMET01501 | |
| 0.103 | 0.192 | 0.145 | Pregnane X receptor agonist | 0.145 0.063 DBMET01501 | DBMET01501 | |
| 0.1 | 0.189 | 0.148 | MAP kinase kinase 2 inhibitor | 0.148 0.123 DBMET01501 | DBMET01501 | |
| 0.063 | 0.153 | 0.084 | Xanthine oxidase inhibitor | 0.084 0.082 DBMET01577 | DBMET01577 | |
| 0.074 | 0.167 | 0.107 | Toll-Like receptor 2 antagonist | 0.107 0.093 DBMET01577 | DBMET01577 | |
| 0.056 | 0.149 | 0.085 | MAP kinase 8 inhibitor | 0.085 0.081 DBMET01501 | DBMET01501 | |
| 0.05 | 0.144 | 0.093 | Urease inhibitor | 0.093 0.075 DBMET01501 | DBMET01501 | |
| 0.128 | 0.228 | 0.196 | Superoxide dismutase inhibitor | 0.196 0.122 DBMET01501 | DBMET01501 | |
| 0.045 | 0.145 | 0.131 | Protein kinase (CK2) inhibitor | 0.131 0.042 DBMET01501 | DBMET01501 | |
| 0.149 | 0.254 | 0.233 | Insulysin inhibitor | 0.233 0.113 DBMET01501 | DBMET01501 | |
| 0.124 | 0.231 | 0.17 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.153 0.143 DBMET01577 0.17 0.108 DBMET01501 | DBMET01501 | |
| 0.085 | 0.196 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 DBMET01501 | DBMET01501 | |
| 0.042 | 0.156 | 0.075 | Histamine N-methyltransferase inhibitor | 0.075 0.072 DBMET01501 | DBMET01501 | |
| 0.082 | 0.201 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.171 0.1 DBMET01501 | DBMET01501 | |
| 0.145 | 0.269 | 0.252 | Alpha-glucosidase inhibitor | 0.252 0.186 DBMET01577 | DBMET01577 | |
| 0.029 | 0.155 | 0.061 | Botulinum neurotoxin type A inhibitor | 0.061 0.036 DBMET01501 | DBMET01501 | |
| 0.097 | 0.223 | 0.176 | Antiamyloidogenic | 0.157 0.138 DBMET01577 0.176 0.117 DBMET01501 | DBMET01501 | |
| 0.017 | 0.146 | 0.044 | Thymidylate synthase inhibitor | 0.044 0.036 DBMET01501 | DBMET01501 | |
| 0.04 | 0.174 | 0.073 | Glycine receptor antagonist | 0.073 0.068 DBMET01501 | DBMET01501 | |
| 0.179 | 0.314 | 0.279 | Calcium channel L-type activator | 0.279 0.175 DBMET01576 0.24 0.217 DBMET01577 | DBMET01576 | |
| 0.02 | 0.155 | 0.069 | NMDA 2 receptor antagonist | 0.069 0.052 DBMET01501 | DBMET01501 | |
| 0.096 | 0.235 | 0.221 | Free radical scavenger | 0.18 0.114 DBMET01576 0.221 0.082 DBMET01577 | DBMET01577 | |
| 0.059 | 0.199 | 0.138 | Lipid peroxidase inhibitor | 0.109 0.106 DBMET01576 0.138 0.077 DBMET01577 | DBMET01577 | |
| 0.065 | 0.208 | 0.109 | Cathepsin H inhibitor | 0.109 0.091 DBMET01501 | DBMET01501 | |
| 0.21 | 0.36 | 0.323 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.323 0.183 DBMET01501 | DBMET01501 | |
| 0.024 | 0.189 | 0.068 | Phosphodiesterase 4B inhibitor | 0.068 0.045 DBMET01501 | DBMET01501 | |
| 0.105 | 0.278 | 0.158 | Growth factor agonist | 0.158 0.124 DBMET01501 | DBMET01501 | |
| 0.059 | 0.24 | 0.148 | Amyloid beta aggregation inhibitor | 0.148 0.11 DBMET01577 | DBMET01577 | |
| 0.091 | 0.273 | 0.209 | Antioxidant | 0.173 0.139 DBMET01576 0.209 0.108 DBMET01577 | DBMET01577 | |
| 0.119 | 0.303 | 0.178 | Neuropeptide Y2 antagonist | 0.178 0.163 DBMET01501 | DBMET01501 | |
| 0.058 | 0.26 | 0.141 | EphB2 antagonist | 0.141 0.139 DBMET01501 | DBMET01501 | |
| 0.048 | 0.3 | 0.119 | Estrogen antagonist | 0.119 0.057 DBMET01576 0.119 0.056 DBMET01577 | DBMET01577 | |
| 0.029 | 0.376 | 0.102 | Estrogen receptor beta antagonist | 0.099 0.067 DBMET01576 0.102 0.061 DBMET01577 | DBMET01577 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |